Il-Sup Huh
Fortuna: 57 M $ al 30/09/2026
Fortuna: 57 M $ al 30/09/2026
Dr. Il-Sup Huh is a Vice President at Korean Association of Tuberclosis Eradication, a Chairman & Co-Chief Executive Officer at GC Corp., a Chairman-Executive Board at GC Biopharma Corp.
and a Chief Executive Officer & Director at Green Cross Vaccine.
He is on the Board of Directors at Korea Biotechnology Industry Organization and Green Cross Vaccine.
Dr. Huh was previously employed as a Chairman by Korea Pharmaceutical Manufacturers Association, a Co-Chief Executive Officer & Director by GC Medical Science Corp., and a Managing Director by HANIL HOLDINGS Co., Ltd. He received his undergraduate degree from Seoul National University, an MBA from Indiana University and a doctorate degree from the University of Houston.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
GC CORP. 12,29 % | 18/09/2026 | 5.777.777 ( 12,29 % ) | 41 M $ | 30/09/2026 |
GC BIOPHARMA CORP. 0,57 % | 30/06/2026 | 66.173 ( 0,57 % ) | 6 M $ | 30/09/2026 |
| 31/03/2026 | 2.193.520 ( 9,15 % ) | 5 M $ | 30/09/2026 | |
HANIL CEMENT Co., Ltd.
HANIL CEMENT Co., Ltd. Construction MaterialsNon-Energy Minerals Manufactures cement and concrete products 0,25 % | 24/08/2026 | 185.000 ( 0,25 % ) | 2 M $ | 30/09/2026 |
HANIL HOLDINGS CO., LTD. 0,41 % | 14/10/2026 | 125.195 ( 0,41 % ) | 2 M $ | 30/09/2026 |
GREEN CROSS WellBeing Corp.
GREEN CROSS WellBeing Corp. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products, research & development of natural medicine 0,47 % | 30/06/2026 | 85.000 ( 0,47 % ) | 622 350 $ | 30/09/2026 |
GC Cell Corp.
GC Cell Corp. BiotechnologyHealth Technology Develops disease therapy and immunocell therapy products using stem cells and natural killer cells 0,19 % | 30/06/2026 | 30.000 ( 0,19 % ) | 310 972 $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| GC BIOPHARMA CORP. | Corporate Officer/Principal | 21/03/2014 |
| GC CORP. | Director Ejecutivo | 25/03/2010 |
Korea Biotechnology Industry Organization | Director/Miembro de la Junta | 15/06/2011 |
Korean Association of Tuberclosis Eradication | Corporate Officer/Principal | 15/06/2011 |
Green Cross Vaccine | Director Ejecutivo | 15/06/2011 |
| Empresas | Cargo | Fin |
|---|---|---|
Korea Pharmaceutical Manufacturers Association | Presidente | 01/01/2006 |
| GC MEDICAL SCIENCE CORPORATION | Director Ejecutivo | - |
| HANIL HOLDINGS CO., LTD. | Director/Miembro de la Junta | 01/01/1990 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 11 |
|---|---|
GC Biopharma Corp.
GC Biopharma Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
HANIL HOLDINGS Co., Ltd.
HANIL HOLDINGS Co., Ltd. Construction MaterialsNon-Energy Minerals Operates as in investment holding company which provides cement and other construction materials, IT solutions, and construction services | Non-Energy Minerals |
Green Cross Holdings Corp.
Green Cross Holdings Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Indiana University
Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Houston
University of Houston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seoul National University
Seoul National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Green Cross Vaccine | |
Green Cross Medical Science Corp.
Green Cross Medical Science Corp. Medical SpecialtiesHealth Technology Engages in the manufacture and sale of in vitro diagnostic reagent products, medical equipment, and other medical supplies | Health Technology |
Korea Pharmaceutical Manufacturers Association | |
Korea Biotechnology Industry Organization | |
Korean Association of Tuberclosis Eradication |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.